Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
57%(4 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
6
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
87.5%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

unknown111%
completed778%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9